MED-EL Medical Electronics, a leader in implantable hearing solutions, is driven by a mission to overcome hearing loss as a barrier to communication and quality of life. The Austrian-based, privately owned business was co-founded by award-winning industry pioneers Ingeborg and Erwin Hochmair, whose ground-breaking research led to the development of the world’s first micro-electronic multi-channel cochlear implant (CI). Successfully implanted in 1977, it was the basis for what is known as the modern CI today. It also laid the foundation for the successful growth of the company in 1990, when MED-EL’s first employees joined the Hochmair’s to bring CIs to people across the world. To date, MED-EL has grown to more than 2,200 employees from around 75 nations and has offices in 30 locations worldwide.
The company now offers the widest range of implantable and non-implantable solutions to treat all types of hearing loss, enabling people in 124 countries to enjoy the gift of hearing with the help of a MED-EL device. MED-EL’s hearing solutions include cochlear and middle ear implant systems, a combined Electric Acoustic Stimulation hearing implant system, auditory brainstem implant, as well as surgical and non-surgical bone conduction devices.
More than 95% of the hearing devices, which are produced in Austria, are exported all around the world to be used by more than 4,000 clinics. www.medel.com